Skip to Content

M 1 L Z (Lamivudine and Zidovudine 150 mg / 300 mg)

Pill with imprint M 1 L Z is White, Capsule-shape and has been identified as Lamivudine and Zidovudine 150 mg / 300 mg. It is supplied by Mylan Pharmaceuticals Inc..

Lamivudine/zidovudine is used in the treatment of occupational exposure; nonoccupational exposure; hiv infection and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Lamivudine/zidovudine 150 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 1 L Z

Lamivudine and zidovudine 150 mg / 300 mg M 1 L Z

Lamivudine and Zidovudine

Imprint:
M 1 L Z
Strength:
150 mg / 300 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiviral combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-5180

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide